Insights on Patent

The 2019 edition of Legal 500 US has rated 49 Arent Fox LLP attorneys as national leaders in their field. In addition, 15 of the firm’s practice areas were ranked among the best in the country.

On May 31st, New York partner Alex Spiegler will be speaking at the 7th Annual World Life Sciences Conference.

Schiff Hardin LLP is pleased to announce that three of the firm’s practice groups have been recognized for the fourth year in a row in The Legal 500 United States 2019 guide, which provides a nationwide analysis of law firms that provide cutting-edge and innovative advice.

Schiff Hardin is pleased to announce that the firm has been ranked as ‘Recommended’ by Managing Intellectual Property magazine in the Illinois IP Stars Patent Contentious category, which includes dispute resolution work, litigation and enforcement, as well as Hatch-Waxman, International Trade Commission, and multinational litigation work.

Law360

On May 6, New York partner Alex Spiegler hosted a webinar Yeshiva University’s Katz School of Science and Health.

On May 7, New York partner Michael Fainberg will be a panelist for TiECon in Boston, the largest entrepreneur conference on the East Coast.

WASHINGTON, DC – Chambers USA: America’s Leading Lawyers for Business has recognized 31 Arent Fox LLP attorneys as leaders in their field.

On April 30th, Arent Fox partner Alex Spiegler is hosting a 30-minute webinar entitled, “Benefits of US Patent Examiner Interviews.”

Law360

Schiff Hardin is pleased to announce that four practice areas and 23 attorneys have been recognized in the 2019 edition of Chambers USA, a leading legal industry ranking.

LOS ANGELES — Craig Gelfound, head of Arent Fox LLP’s Intellectual Property practice in Los Angeles, has once again been honored by the Daily Journal as one of the Top Intellectual Property Lawyers in California, marking his ninth consecutive year of this recognition.

National Journal

On March 26 Arent Fox together with the Loyens & Loeff Life Sciences Team will organize an afternoon seminar about the patenting of Life Sciences and Food-related inventions in the U.S.

De Gaulle Fleurance & Associés & Arent Fox are pleased to invite you to a breakfast-conference entitled, “Patent Ownership and Salaried Investors: French-US Perspective.”

Arent Fox has successfully procured another patent for Acronis, a leading provider of cloud backup and data management services, covering a new technology for watermarking digital content using a blockchain network.

Law360

The Center for Biosimilars

CQ News

The Pharma Letter

The United States Patent and Trademark Office greeted the new year with a welcome gift: “2019 Revised Patent Subject Matter Eligibility Guidance” that updates the framework on subject matter eligibility under 35 U.S.C. § 101. 

As the government shutdown stretches on, pharmaceutical companies must manage the partial shutdown of the U.S. Food and Drug Administration (FDA).

IPWatchdog

Schiff Hardin successfully secured a favorable outcome for our client, Fresenius Kabi USA LLC, in a patent-infringement suit filed by Hospira Inc., which paves the way for Fresenius to market a new generic drug.

The Center for Biosimilars